Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Chemistry|December 14, 2012
Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitorsIvanhoe K H Leung, Marina Demetriades, Adam P Hardy, et al.Journal of Molecular Biology|August 23, 2017
Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle IntermediatesHanna Tarhonskaya, Radosław P Nowak, Catrine Johansson, et al.Epigenetics|July 2, 2020
Hypoxia and hypoxia mimetics differentially modulate histone post-translational modificationsKuo-Feng Hsu, Sarah E Wilkins, Richard J Hopkinson, et al.Anti-Cancer Drugs|November 29, 2007
Synthesis and anticancer activities of 6-amino amonafide derivativesJohn T Norton, Mark A Witschi, Lynn Luong, et al.Bioorganic & Medicinal Chemistry|January 23, 2024
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profilingKlemensas Šimelis, Hilal Saraç, Eidarus Salah, et al.Chemical Communications (Cambridge, England)|July 3, 2018
Human histone demethylase KDM6B can catalyse sequential oxidationsRichard J Hopkinson, Gareth W Langley, Roman Belle, et al.Communications Biology|November 28, 2024
JmjC catalysed histone H2a N-methyl arginine demethylation and C4-arginine hydroxylation reveals importance of sequence-reactivity relationshipsJoanna Bonnici, Razanne Oueini, Eidarus Salah, et al.Bioorganic & Medicinal Chemistry|December 9, 2008
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2Angela J Russell, Isaac M Westwood, Matthew H J Crawford, et al.Journal of Medicinal Chemistry|January 31, 2024
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-HydroxyglutarateRoman Belle, Hilal Saraç, Eidarus Salah, et al.RSC Chemical Biology|May 23, 2025
RaPID discovery of cell-permeable helical peptide inhibitors con-taining cyclic β-amino acids against SARS-CoV-2 main proteaseMarina Kawai, Tika R Malla, H T Henry Chan, et al.Pageof 11